HEADER OXIDOREDUCTASE 15-NOV-18 6I6C TITLE SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SEPIAPTERIN REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SPR; COMPND 5 EC: 1.1.1.153; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SPR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: NICO; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS SEPIAPTERIN-REDUCTASE, OXIDOREDUCTASE, PROTEROS BIOSTRUCTURES GMBH EXPDTA X-RAY DIFFRACTION AUTHOR J.ALEN,M.SCHADE,M.WAGENER,M.BLAESSE REVDAT 3 15-MAY-24 6I6C 1 REMARK REVDAT 2 24-JUL-19 6I6C 1 JRNL REVDAT 1 10-JUL-19 6I6C 0 JRNL AUTH J.ALEN,M.SCHADE,M.WAGENER,F.CHRISTIAN,S.NORDHOFF,B.MERLA, JRNL AUTH 2 T.R.DUNKERN,G.BAHRENBERG,P.RATCLIFFE JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL POTENT SEPIAPTERIN JRNL TITL 2 REDUCTASE INHIBITORS. JRNL REF J.MED.CHEM. V. 62 6391 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31244106 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00218 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 48018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2640 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.72 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3552 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 191 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3947 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 168 REMARK 3 SOLVENT ATOMS : 235 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15000 REMARK 3 B22 (A**2) : -0.08000 REMARK 3 B33 (A**2) : 0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.196 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.113 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.623 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4245 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4160 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5781 ; 1.681 ; 2.048 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9547 ; 1.699 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 545 ; 5.830 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 162 ;37.927 ;23.889 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 708 ;11.093 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;20.833 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 669 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4764 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 927 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2127 ; 3.124 ; 3.202 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2126 ; 3.118 ; 3.201 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2664 ; 3.255 ; 5.403 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2665 ; 3.257 ; 5.403 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2118 ; 4.361 ; 3.845 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2118 ; 4.358 ; 3.845 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3109 ; 4.619 ; 6.189 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4588 ; 4.419 ;30.620 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4559 ; 4.401 ;30.479 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8405 ; 2.869 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 149 ;19.918 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 8418 ; 7.464 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6I6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200012885. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50658 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 63.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.39400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.00 %W/V PEG 3350, 0.10 M BIS-TRIS REMARK 280 PROPAN PH=6.50, 0.10 M NABR, VAPOR DIFFUSION, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.95650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.60700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.66050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.60700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.95650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.66050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 GLY A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 ARG A 58 REMARK 465 SER A 59 REMARK 465 LYS A 261 REMARK 465 MET B -14 REMARK 465 GLY B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 GLY B 3 REMARK 465 LYS B 261 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 73 CD OE1 OE2 REMARK 480 ARG A 84 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 85 CD OE1 OE2 REMARK 480 LYS A 90 CG CD CE NZ REMARK 480 GLN A 119 CD OE1 NE2 REMARK 480 LYS A 140 NZ REMARK 480 LYS A 247 NZ REMARK 480 GLU B 57 CG CD OE1 OE2 REMARK 480 SER B 59 OG REMARK 480 GLU B 73 CD OE1 OE2 REMARK 480 LYS B 109 NZ REMARK 480 MET B 218 CE REMARK 480 LYS B 220 CG CD CE NZ REMARK 480 LYS B 228 CE NZ REMARK 480 LYS B 230 CD CE NZ REMARK 480 GLU B 246 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 65 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 156 -156.89 -101.23 REMARK 500 ARG B 58 -81.92 -24.54 REMARK 500 SER B 156 -157.32 -107.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H4H A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H4H B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 306 DBREF 6I6C A 1 261 UNP P35270 SPRE_HUMAN 1 261 DBREF 6I6C B 1 261 UNP P35270 SPRE_HUMAN 1 261 SEQADV 6I6C MET A -14 UNP P35270 INITIATING METHIONINE SEQADV 6I6C GLY A -13 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -12 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -11 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -10 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -9 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -8 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS A -7 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLU A -6 UNP P35270 EXPRESSION TAG SEQADV 6I6C ASN A -5 UNP P35270 EXPRESSION TAG SEQADV 6I6C LEU A -4 UNP P35270 EXPRESSION TAG SEQADV 6I6C TYR A -3 UNP P35270 EXPRESSION TAG SEQADV 6I6C PHE A -2 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLN A -1 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLY A 0 UNP P35270 EXPRESSION TAG SEQADV 6I6C MET B -14 UNP P35270 INITIATING METHIONINE SEQADV 6I6C GLY B -13 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -12 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -11 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -10 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -9 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -8 UNP P35270 EXPRESSION TAG SEQADV 6I6C HIS B -7 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLU B -6 UNP P35270 EXPRESSION TAG SEQADV 6I6C ASN B -5 UNP P35270 EXPRESSION TAG SEQADV 6I6C LEU B -4 UNP P35270 EXPRESSION TAG SEQADV 6I6C TYR B -3 UNP P35270 EXPRESSION TAG SEQADV 6I6C PHE B -2 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLN B -1 UNP P35270 EXPRESSION TAG SEQADV 6I6C GLY B 0 UNP P35270 EXPRESSION TAG SEQRES 1 A 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU SEQRES 3 A 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA SEQRES 4 A 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU SEQRES 5 A 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU SEQRES 6 A 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL SEQRES 7 A 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU SEQRES 8 A 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO SEQRES 9 A 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY SEQRES 10 A 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER SEQRES 11 A 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU SEQRES 12 A 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA SEQRES 13 A 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN SEQRES 14 A 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP SEQRES 15 A 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU SEQRES 16 A 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL SEQRES 17 A 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN SEQRES 18 A 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG SEQRES 19 A 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL SEQRES 20 A 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU SEQRES 21 A 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE SEQRES 22 A 276 TYR ASP LYS SEQRES 1 B 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 B 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU SEQRES 3 B 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA SEQRES 4 B 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU SEQRES 5 B 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU SEQRES 6 B 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL SEQRES 7 B 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU SEQRES 8 B 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO SEQRES 9 B 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY SEQRES 10 B 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER SEQRES 11 B 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU SEQRES 12 B 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA SEQRES 13 B 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN SEQRES 14 B 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP SEQRES 15 B 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU SEQRES 16 B 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL SEQRES 17 B 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN SEQRES 18 B 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG SEQRES 19 B 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL SEQRES 20 B 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU SEQRES 21 B 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE SEQRES 22 B 276 TYR ASP LYS HET NAP A 301 48 HET H4H A 302 35 HET EDO A 303 4 HET EDO A 304 4 HET EDO A 305 4 HET NAP B 301 48 HET H4H B 302 22 HET EDO B 303 4 HET EDO B 304 4 HET EDO B 305 4 HET EDO B 306 4 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM H4H (1~{R},2~{S},4~{S})-~{N}-(3-CHLORANYL-4-CYANO-PHENYL) HETNAM 2 H4H SULFONYLBICYCLO[2.2.1]HEPTANE-2-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 H4H 2(C15 H15 CL N2 O3 S) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 14 HOH *235(H2 O) HELIX 1 AA1 HIS A -7 GLN A -1 5 7 HELIX 2 AA2 ARG A 17 LEU A 30 1 14 HELIX 3 AA3 ASN A 43 GLU A 57 1 15 HELIX 4 AA4 ALA A 72 LEU A 86 1 15 HELIX 5 AA5 GLY A 110 LEU A 114 5 5 HELIX 6 AA6 ASP A 116 LEU A 128 1 13 HELIX 7 AA7 LEU A 128 PHE A 142 1 15 HELIX 8 AA8 SER A 157 LEU A 161 5 5 HELIX 9 AA9 TRP A 167 GLU A 188 1 22 HELIX 10 AB1 THR A 203 SER A 213 1 11 HELIX 11 AB2 ASP A 215 LYS A 228 1 14 HELIX 12 AB3 ASP A 233 ASP A 248 1 16 HELIX 13 AB4 ARG B 17 SER B 29 1 13 HELIX 14 AB5 ASN B 43 GLU B 57 1 15 HELIX 15 AB6 ALA B 72 GLU B 85 1 14 HELIX 16 AB7 GLY B 110 LEU B 114 5 5 HELIX 17 AB8 ASP B 116 LEU B 128 1 13 HELIX 18 AB9 LEU B 128 PHE B 142 1 15 HELIX 19 AC1 SER B 157 LEU B 161 5 5 HELIX 20 AC2 TRP B 167 GLU B 188 1 22 HELIX 21 AC3 THR B 203 SER B 213 1 11 HELIX 22 AC4 ASP B 215 LYS B 228 1 14 HELIX 23 AC5 ASP B 233 ASP B 248 1 16 SHEET 1 AA1 7 ARG A 62 PRO A 67 0 SHEET 2 AA1 7 VAL A 36 ALA A 41 1 N LEU A 39 O VAL A 66 SHEET 3 AA1 7 ALA A 8 LEU A 12 1 N CYS A 10 O VAL A 38 SHEET 4 AA1 7 ARG A 94 ASN A 99 1 O ILE A 98 N LEU A 11 SHEET 5 AA1 7 ASN A 149 ILE A 155 1 O VAL A 153 N ASN A 99 SHEET 6 AA1 7 ARG A 192 ALA A 197 1 O ARG A 192 N ARG A 150 SHEET 7 AA1 7 ALA A 254 ASP A 257 1 O VAL A 256 N ASN A 195 SHEET 1 AA2 7 ARG B 62 PRO B 67 0 SHEET 2 AA2 7 VAL B 36 ALA B 41 1 N LEU B 37 O ARG B 62 SHEET 3 AA2 7 ALA B 8 THR B 13 1 N CYS B 10 O VAL B 38 SHEET 4 AA2 7 ARG B 94 ASN B 99 1 O ILE B 98 N LEU B 11 SHEET 5 AA2 7 ASN B 149 ILE B 155 1 O THR B 151 N LEU B 95 SHEET 6 AA2 7 VAL B 191 ALA B 197 1 O ARG B 192 N ARG B 150 SHEET 7 AA2 7 HIS B 255 ASP B 257 1 O VAL B 256 N ASN B 195 SITE 1 AC1 35 GLY A 14 SER A 16 ARG A 17 GLY A 18 SITE 2 AC1 35 PHE A 19 ALA A 41 ARG A 42 ASN A 43 SITE 3 AC1 35 ALA A 68 ASP A 69 LEU A 70 ASN A 100 SITE 4 AC1 35 ALA A 101 LEU A 126 ILE A 155 SER A 156 SITE 5 AC1 35 TYR A 170 LYS A 174 PRO A 198 GLY A 199 SITE 6 AC1 35 PRO A 200 LEU A 201 THR A 203 MET A 205 SITE 7 AC1 35 GLN A 206 H4H A 302 EDO A 303 HOH A 407 SITE 8 AC1 35 HOH A 431 HOH A 437 HOH A 442 HOH A 444 SITE 9 AC1 35 HOH A 451 HOH A 466 HOH A 468 SITE 1 AC2 13 SER A 157 LEU A 158 CYS A 159 PHE A 164 SITE 2 AC2 13 TYR A 170 GLY A 199 PRO A 200 GLN A 206 SITE 3 AC2 13 ALA A 209 LEU A 222 LEU A 225 NAP A 301 SITE 4 AC2 13 HOH A 478 SITE 1 AC3 5 ARG A 17 ASP A 204 MET A 205 NAP A 301 SITE 2 AC3 5 HOH A 491 SITE 1 AC4 5 SER A 103 LEU A 104 GLY A 105 LEU A 208 SITE 2 AC4 5 HOH A 437 SITE 1 AC5 7 GLU A -6 GLY A 6 ARG A 7 SER A 32 SITE 2 AC5 7 GLN A 93 HOH A 404 GLN B 162 SITE 1 AC6 34 GLY B 14 SER B 16 ARG B 17 GLY B 18 SITE 2 AC6 34 PHE B 19 ALA B 41 ARG B 42 ASN B 43 SITE 3 AC6 34 ALA B 68 ASP B 69 LEU B 70 ASN B 100 SITE 4 AC6 34 LEU B 126 ILE B 155 SER B 156 TYR B 170 SITE 5 AC6 34 LYS B 174 PRO B 198 GLY B 199 LEU B 201 SITE 6 AC6 34 THR B 203 ASP B 204 MET B 205 GLN B 206 SITE 7 AC6 34 H4H B 302 EDO B 303 HOH B 414 HOH B 430 SITE 8 AC6 34 HOH B 438 HOH B 443 HOH B 452 HOH B 453 SITE 9 AC6 34 HOH B 473 HOH B 476 SITE 1 AC7 12 PHE A -2 TYR A -3 SER B 157 LEU B 158 SITE 2 AC7 12 CYS B 159 TYR B 170 GLN B 206 ALA B 209 SITE 3 AC7 12 LEU B 222 LEU B 225 NAP B 301 HOH B 481 SITE 1 AC8 3 ARG B 17 ASP B 204 NAP B 301 SITE 1 AC9 5 SER B 103 LEU B 104 GLY B 105 LEU B 208 SITE 2 AC9 5 HOH B 438 SITE 1 AD1 3 ASP B 69 GLY B 71 ASN B 122 SITE 1 AD2 4 GLU A 73 GLN A 77 SER B 115 SER B 117 CRYST1 113.913 77.321 59.214 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008779 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012933 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016888 0.00000